Results 131 to 140 of about 20,820 (198)

Microbicide Vaginal Rings: Technological Challenges and Clinical Development [PDF]

, 2016
Boyd, Peter J., Malcolm, R. Karl, McCoy, Clare F., Murphy, Diarmaid J.   +3 more
core   +1 more source

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083. [PDF]

Open Forum Infect Dis
Moore HP, Fogel JM, Marzinke MA, Halvas EK, Parikh UM, Mellors JW, Penrose KJ, Seisa M, Petropoulos C, Price AL, Moser A, Wang Z, McCauley M, Valencia-Huamaní J, Rinehart AR, Rooney JF, Soto-Torres L, Grinsztejn B, Landovitz RJ, Eshleman SH.   +19 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Long-term metabolic and safety profiles of tenofovir alafenamide and tenofovir disoproxil fumarate in ART-naive people living with HIV: a multicenter retrospective study using a mixed-effects model. [PDF]

BMC Pharmacol Toxicol
Karabay O, Vatan A, Ucar A, Yilmaz I, Balta NC, Kanturk A, Dumlu R, Cag Y, Caskurlu H, Şik MT, Otman ZA, Balci U, Senbayrak S, Akhan S, Deniz MT, Yekenkurul D, Ince N, Tunca B, Cakirca TD, Bastug A, Erkorkmaz U, Guclu E.   +21 more
europepmc   +1 more source

Weight gain on tenofovir alafenamide fumarate-based therapy compared to tenofovir disoproxil fumarate- and abacavir-based therapy in children and young people living with HIV in Europe. [PDF]

HIV Med
European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group.
europepmc   +1 more source

Economic evaluation of HIV-exposure Prophylaxis among men-who have sex with men in England: Supplementary material [PDF]

, 2017
van Hoek, AJ
core  

Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/ TDF) treatment in people living with HIV: A single-center real-world experience from Belgrade, Serbia. [PDF]

Germs
Markovic M, Ranin J, Despotovic A, Rajkovic I, Ranin J, Tanasijevic M, Mitrovic N, Nikolic N, Milosevic I, Gmizic I.   +9 more
europepmc   +1 more source

Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis. [PDF]

BMC Infect Dis
Chen L, Zhang HF, Cai YJ, Zhang L, Cai C, Lu MQ, Zhu YY.   +6 more
europepmc   +1 more source

Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China. [PDF]

Front Med (Lausanne)
Li A, Liu L, Zhang H, Wang X, Li Z, Liu A, Dai L, Zhang J, Gao Y, Ye J, Li J, Sun L.   +11 more
europepmc   +1 more source

Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks. [PDF]

PLoS One
Amutuhaire W, Castelnuovo B, Brusselaers N, Nabwana M, Muhammad L, Maloney B, Nixon B, Schwarz JM, Mulindwa F.   +8 more
europepmc   +1 more source